* Verastem Inc is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Verastem Inc is for a loss of $1.03 per share.
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the last three months.
* Wall Street's median 12-month price target for Verastem Inc is $32.00, above its last closing price of $10.36.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.74 -0.62 -1.02 Missed -64.5
Sep. 30 2023 -0.87 -0.84 -0.75 Beat 11
Jun. 30 2023 -1.07 -1.06 -1.37 Missed -29.2
Mar. 31 2023 -0.96 -0.98 -0.96 Beat 2.4
Dec. -1.20 -1.18 -0.96 Beat 18.4
31 2022
Sep. 30 2022 -1.46 -1.46 -1.08 Beat 26
Jun. 30 2022 -1.32 -1.32 -1.44 Missed -9.1
Mar. 31 2022 -0.97 -0.98 -1.08 Missed -9.8
This summary was machine generated May 3 at 12:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments